OncoPep (Series D)
Funding Details
Awarder
Inbox
Date Award
December 9, 2021
Vertical
Biotechnology
Funding Amount
$11,000,000
Company Info
Founding Year
2010
Market
Cancer Treatment
Location
North Andover, MA, USA
Coinvestors
CrystalBioScience, Kukje Pharma, SX Company, Tera Science
Company Description

OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.

Links